Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, PET, ANW

New Digital Diagnosis and Treatment Tool, GekkoVet, Secures Finalist Position in Animal Health Innovation Summit


HELSINKI, June 16, 2022 /PRNewswire/ -- Finnish company, GekkoVet, is proud to announce their participation as showcase finalist in the Animal Health, Nutrition & Technology Innovation summit in Boston, MA on June 22nd. GekkoVet has been rapidly expanding into the animal health market and the Innovation Summit serves as a launching platform for mass market adoption in the US.

GekkoVet is a digital diagnostic and treatment tool that is based on over 50,000 pages of clinical source material to help veterinarians quickly choose from the list of clinical symptoms to return over 28,000 different symptom-diagnosis combinations. The proprietary GekkoVet algorithm returns the diagnoses list in probability order to improve the quality and speed of clinical decision making.

Arbor Pointe Veterinary Hospital owner and veterinarian Dr. Mike Petty commented, "In the face of severe staff shortages that aren't going anywhere soon our industry has no choice but to evolve to survive. For too long we've relied on Google and stacks of books for our reference needs. Everything else is accessible from a few taps on a cell phone?except clinical (decision making) tools."

GekkoVet's mission is to increase the efficiency by digitalizing clinical decision making to bridge the gap. The AVMA predicts a shortage of 15,000 veterinarians by the end of the decade in the face of growing pet ownership.

GekkoVet Co-Founder and veterinarian Dr. Johanna Majamaa notes, "GekkoVet isn't here to replace the experience and knowledge of veterinarians. We are here to be their right hand. Nobody can recall thousands of pages of source material, instead of Googling it we're here to help clinician's Gekko it to improve efficiency."

The GekkoVet team is actively seeking investors in the US market and looks forward to presenting the future of digital decision making at the Animal Health Innovation Summit in Boston.

Contact:
www.GekkoVet.com
Johanna Majamaa
Co-Founder, CEO
[email protected]
+358 45 189 6144

Photo: https://mma.prnewswire.com/media/1840922/GekkoVet.jpg 
Logo: https://mma.prnewswire.com/media/1840923/GekkoVet.jpg

SOURCE Gekkovet International Oy


These press releases may also interest you

at 08:20
Intercontinental Exchange, Inc. Announces Early Tender Results of Previously Announced Private Exchange Offer for Black Knight InfoServ, LLC's Outstanding 3.625% Senior Notes due 2028
Intercontinental Exchange, Inc. ("ICE") announced today that as of 5:00 p.m., New York City time, on May 16, 2024 (the "Early Tender Deadline"), $997.4 million in aggregate principal amount of outstanding 3.625% Senior Notes due 2028 (CUSIP:...

at 08:10
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guardant Health, Inc. , a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units ("RSUs") representing 215,601 shares of...

at 08:08
Victoria Eye Center/Victoria Surgery Center/Victoria Vision Center Notice of Data Breach
Victoria Eye Center/Victoria Surgery Center/Victoria Vision Center ("VEC") is writing to provide information regarding an event that involves certain information relating to personal health information.  On March 21, 2024, VEC became aware that...

at 08:05
CCC Intelligent Solutions Inc. to Present at Upcoming Investor Conferences
CCC Intelligent Solutions Holdings Inc. (CCC) , a leading cloud platform powering the P&C insurance economy, today announced that management will present at the following investor conferences: The J.P. Morgan Global Technology, Media and...

at 08:05
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced preclinical data from the Company's platform and pipeline. The data are being presented on Friday, May 17,...

at 08:05
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the promotion of Max Rosett to Chief Financial Officer, effective May 9. Mr. Rosett most recently held the role...

More news about Science and technology...


News published on and distributed by: